A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dexfenfluramine
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Safinamide.
Dexfenfluramine
Diamorphine
The risk or severity of adverse effects can be increased when Diamorphine is combined with Safinamide.
Dexfenfluramine
Dihydroetorphine
The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Safinamide.
Dexfenfluramine
Methadyl acetate
The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Safinamide.
Dexfenfluramine
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Safinamide.
Dexfenfluramine
Brofaromine
The risk or severity of adverse effects can be increased when Safinamide is combined with Brofaromine.
Dexfenfluramine
Harmaline
The risk or severity of adverse effects can be increased when Safinamide is combined with Harmaline.
Dexfenfluramine
Caroxazone
The risk or severity of adverse effects can be increased when Safinamide is combined with Caroxazone.
Dexfenfluramine
Safrazine
The risk or severity of adverse effects can be increased when Safinamide is combined with Safrazine.
Dexfenfluramine
Pivhydrazine
The risk or severity of adverse effects can be increased when Safinamide is combined with Pivhydrazine.
Dexfenfluramine
Phenoxypropazine
The risk or severity of adverse effects can be increased when Safinamide is combined with Phenoxypropazine.
Dexfenfluramine
Pheniprazine
The risk or severity of adverse effects can be increased when Safinamide is combined with Pheniprazine.
Dexfenfluramine
Octamoxin
The risk or severity of adverse effects can be increased when Safinamide is combined with Octamoxin.
Dexfenfluramine
Mebanazine
The risk or severity of adverse effects can be increased when Safinamide is combined with Mebanazine.
Dexfenfluramine
Benmoxin
The risk or severity of adverse effects can be increased when Safinamide is combined with Benmoxin.
Dexfenfluramine
Toloxatone
The risk or severity of adverse effects can be increased when Safinamide is combined with Toloxatone.
Dexfenfluramine
Pirlindole
The risk or severity of adverse effects can be increased when Safinamide is combined with Pirlindole.
Dexfenfluramine
Hydracarbazine
The risk or severity of adverse effects can be increased when Safinamide is combined with Hydracarbazine.
Dexfenfluramine
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when Safinamide is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.
Dexfenfluramine
Nialamide
The risk or severity of adverse effects can be increased when Nialamide is combined with Safinamide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3